title: [Post-hysterectomy vesicovaginal fistula].
abstract: OBJECTIVE
  Describe the epidemiology, diagnosis and treatment of vesicovaginal fistula (VVF).
  
  
  METHODS
  We conducted a retrospective descriptive study of all cases of VVF secondary to hysterectomy. The following parameters were studied: age, parity, indication for hysterectomy, risk factors, the consultation period, the anatomical type of VVF, the paraclinical, the surgical approach and results of the cure.
  
  
  RESULTS
  Fourteen cases were identified over 10 years. All hysterectomies were performed by laparotomia. The average age of patients was 54.3±13 years. Hysterectomy was performed in view of a uterine leiomyoma in eight cases, a cancer of the cervix in four cases, a menometrorrhagia in one case and a choriocarcinoma in one case. Four patients had received neoadjuvant radiotherapy. The mean time from injury was 13.5±18 months. Examination under valve was allowed to find 11 VVF type 1 and three type 2 VVF. IVU was normal in seven patients and allowed to find an ureterohydronephrose stage III in one patient. VVF was addressed by high in ten cases including 5 by transperitoneovaginale and 5 by transvesical pure. The postoperative course was uneventful in 11 patients (78%) but marked by vesicocutaneous fistula, parietal suppuration and one failure.
  
  
  CONCLUSIONS
  In this short series of post-hysterectomy VVF treated by laparotomia, we observed a rate of cure satisfying in spite of an important psychosocial morbidity.
authors.affiliation: Service d'urologie-andrologie, CHU Aristide-Le-Dantec, avenue Pasteur, BP 35354, Dakar, Sénégal. Electronic address: sarramoc@yahoo.fr.
authors.forename: A
authors.initials: A
authors.lastname: Sarr
authors.forename: Y
authors.initials: Y
authors.lastname: Sow
authors.forename: A
authors.initials: A
authors.lastname: Thiam
authors.forename: I
authors.initials: I
authors.lastname: Ngom
authors.forename: B
authors.initials: B
authors.lastname: Fall
authors.forename: B
authors.initials: B
authors.lastname: Diao
authors.forename: P A
authors.initials: PA
authors.lastname: Fall
authors.forename: A K
authors.initials: AK
authors.lastname: Ndoye
authors.forename: M
authors.initials: M
authors.lastname: Ba
authors.forename: B A
authors.initials: BA
authors.lastname: Diagne
mesh_terms: D000328:Adult; D000368:Aged; D002822:Choriocarcinoma / Q000628:therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects*; D007889:Leiomyoma / Q000601:surgery; D008875:Middle Aged; D010298:Parity; D018714:Radiotherapy, Adjuvant / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012307:Risk Factors; D061665:Time-to-Treatment; D002583:Uterine Cervical Neoplasms / Q000628:therapy; D014594:Uterine Neoplasms / Q000601:surgery; D014719:Vesicovaginal Fistula / Q000209:etiology* / Q000601:surgery
keywords: Bon pronostic; Good prognosis; Hysterectomy; Hystérectomie; Iatrogenic lesions; Lésions iatrogènes